CenterStar Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,800
Closed -$633K 246
2026
Q1
$633K Buy
+1,800
New +$642K 0.08% 278
2024
Q1
Sell
-1,500
Closed -$432K 246
2023
Q4
$432K Sell
1,500
-2,000
-57% -$545K 0.06% 207
2023
Q3
$941K Buy
+3,500
New +$873K 0.19% 101
2021
Q3
Hold
0
-$264K 671
2021
Q2
Hold
0
301
2021
Q1
Hold
0
-$2.16M 674
2020
Q4
Hold
0
131
2020
Q3
Hold
0
268
2020
Q2
Hold
0
221
2020
Q1
Hold
0
47
2019
Q4
Hold
0
8
2019
Q3
Hold
0
31
2019
Q1
Hold
0
-$14K 392
2018
Q4
Hold
0
318
2018
Q3
Hold
0
221
2018
Q2
Hold
0
554
2018
Q1
Hold
0
484

Other funds holding AMGN

CenterStar Asset Management's AMGN Position: Q2 2026 in Review

CenterStar Asset Management reduced its Amgen (AMGN) stake by 10% in Q2 2026, selling an estimated $30.8K and leaving 800 shares worth $290K. The position accounts for 0.05% of the portfolio, ranked #191.

CenterStar Asset Management first reported a position in AMGN in Q1 2026 and has held it in 2 quarters since. The position peaked at $313K in Q1 2026. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • CenterStar Asset Management held 800 shares of Amgen worth $290K as of Q2 2026.
  • CenterStar Asset Management sold 90 Amgen shares in Q2 2026, an estimated $30.8K.
  • Amgen made up 0.05% of CenterStar Asset Management's portfolio in Q2 2026, its #191 holding.
  • CenterStar Asset Management first reported a position in Amgen in Q1 2026 and has held it in 2 quarters since.
  • CenterStar Asset Management's Amgen position peaked at $313K in Q1 2026.
  • 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on CenterStar Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.